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Introduction
Adult stem cells are rare cells characterized by the ability to 
self-renew and to generate specialized progeny committed to 
tissue maintenance and repair (Schultz and McCormick, 1994; 
Kuang et al., 2008). The discovery in recent years of tissue- 
specific adult stem cells residing in anatomically and function-
ally defined niches has strengthened the importance of the niche 
in regulating stem cell fate and function (Blanpain et al., 2007; 
Blank et al., 2008; Discher et al., 2009). Satellite cells (SCs), 
the adult skeletal muscle progenitors, reside in a niche that was 
anatomically defined by electron microscopy (Mauro, 1961). 
SCs reside in a pocket within the surface of myofibers, where 
the basolateral side of the SC is exposed to the myofiber plasma 
membrane and the apical side is exposed to the basal lamina. 
The SC niche is thought to play a critical role in defining SC 
homeostasis, as disruption of the SC niche often leads to impaired 
muscle maintenance and impaired regeneration (Cornelison et al., 
2004; Collins et al., 2005; Boonen and Post, 2008). However, 
the  molecular  mechanisms  involved  in  signaling  integration 
within the satellite niche are still poorly understood.
Recently, we identified Syndecan-3 as a component of   
the SC niche. Syndecan-3 is a transmembrane heparan sulfate   
proteoglycan  (HSPG)  expressed  in  SCs  that  interacts  with 
extracellular matrix proteins and growth factors through its 
ectodomain, and with cytoskeletal proteins and intracellular 
signaling molecules through its intracellular domain. Syndecan-3 
plays a role in SC maintenance, proliferation, and differentiation 
(Fuentealba et al., 1999). Syndecan-3–null (sdc3
/) muscles 
regenerate  but  uninjured  sdc3
/  muscles  exhibit  aberrant 
phenotypes, including an increase of myonuclei in myofibers 
(myofiber hyperplasia) and an increase of centrally nucleated 
myofibers  (Cornelison  et  al.,  2004).  Furthermore,  explanted 
sdc3
/  SCs  show  impaired  proliferation  and  differentiation 
in culture, accompanied by altered response to growth factors 
(Cornelison et al., 2004).
S
keletal muscle postnatal growth and repair depend 
on satellite cells and are regulated by molecular 
signals within the satellite cell niche. We investi-
gated the molecular and cellular events that lead to al-
tered myogenesis upon genetic ablation of Syndecan-3,   
a component of the satellite cell niche. In the absence of 
Syndecan-3, satellite cells stall in S phase, leading to re-
duced proliferation, increased cell death, delayed onset 
of differentiation, and markedly reduced numbers of Pax7
+ 
satellite cells accompanied by myofiber hypertrophy and 
an  increased  number  of  centrally  nucleated  myofibers. 
We show that the aberrant cell cycle and impaired self-
renewal of explanted Syndecan-3–null satellite cells are 
rescued by ectopic expression of the constitutively active 
Notch intracellular domain. Furthermore, we show that 
Syndecan-3 interacts with Notch and is required for 
Notch processing by ADAM17/tumor necrosis factor-–
converting enzyme (TACE) and signal transduction. To-
gether, our data support the conclusion that Syndecan-3 
and Notch cooperate in regulating homeostasis of the sat-
ellite cell population and myofiber size.
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30-min BrdU pulse label revealed a greater number of sdc3
/ 
cells in S phase compared with wild-type cells (Fig. 1 D), which 
is  inconsistent  with  the  reduction  in  sdc3
/  cell  expansion. 
When scored for the number of cells in mitosis, we found fewer 
phospho–histone H3
+ (p-H3
+) sdc3
/ cells than wild-type cells 
(Fig. 1 E). Together, these data suggest that the cell cycle kinet-
ics of sdc3
/ and wild-type SCs differ in culture. We tested this 
idea by performing a double-label pulse-chase experiment using 
5-chloro-2-deoxyuridine (CldU) and 5-iodo-2-deoxyuridine 
(IdU) to determine the time that cells spend in S phase. We pulse- 
labeled wild-type and sdc3
/ SC cultures for 30 min with CldU 
followed by either a 4 h or 8 h chase (Fig. S1 A). At the end of each   
chase period, IdU was added for 30 min (Fig. S1 A). Cells with 
an extended S phase will label with both CldU and IdU, whereas 
cells with a shorter S phase will label predominately with either   
CldU or IdU, depending on the chase time. Indeed, more sdc3
/ 
cells than wild-type cells were double-labeled with either the 4 h 
or 8 h chase, which indicates that loss of Syndecan-3 lengthens 
the S-phase of these cells (Fig. 1 F). The double-labeled cells 
clearly show a distinct pattern of CldU and IdU staining, which 
indicates that the two thymidine analogues were incorporated in 
different portions of the replicating genome (Fig. S1 B). This   
result also rules out the possibility of staining artifacts due to 
anti-CldU and anti-IdU antibody cross-reactivity.
In  addition  to  impaired  proliferation,  Syndecan-3  loss 
leads to a delay in the onset of differentiation, dysregulated myo-
blast terminal differentiation, and aberrant fusion (Cornelison   
et al., 2004). Proliferating myoblasts in G1 phase decide whether 
to reenter S phase and progress through another cell cycle or exit 
the cell cycle. Once they are in G0, they either differentiate or 
self-renew (Olguin and Olwin, 2004; Zammit et al., 2004). Thus, 
the delay in differentiation onset observed in sdc3
/ SC cul-
tures (Cornelison et al., 2004) could be a direct consequence   
of the impaired cell cycle progression because cells that have a 
prolonged S phase also delay G1 phase entry. As predicted, we 
found that fewer sdc3
/ than wild-type cells were found in G1 
phase when the cell cycle distribution was analyzed by flow   
cytometry (Fig. S1 C). Because fewer cells in sdc3
/ satellite 
cultures are in G1 at any time, cell cycle exit and Myogenin   
expression is delayed in sdc3
/ cultures compared with wild-
type controls (Fig. S1 D). Cells that stall in S phase are also more 
prone to undergo apoptosis (Maddika et al., 2007), therefore we 
asked whether cell survival was impaired in sdc3
/ SCs. When 
tested for cell death by a TUNEL assay, sdc3
/ cultures had 
more TUNEL
+ cells than wild-type cultures (Fig. 1 G).
Upon  cell  cycle  exit,  muscle  progenitors  in  G0  either 
commit to terminal differentiation and fuse or replenish the un-
differentiated progenitor population (Olguin and Olwin, 2004; 
Zammit et al., 2004). These cell fate decisions are altered in the 
absence of Syndecan-3. At 48 h and 72 h after serum withdrawal, 
sdc3
/ cultures showed larger myotubes (Fig. 1 H; Cornelison 
et al., 2004) and reduced Pax7
+ reserve cells (Fig. 1, H and I)   
compared with wild-type cultures, which indicates that sdc3
/ 
SCs exiting the cell cycle prefer to undergo terminal myo-
genic  differentiation as opposed to self-renewal. Our results 
suggest that a combination of cell cycle lengthening, increased 
cell death, and impaired balance between differentiation and 
Another key component of the SC niche is Notch. In adult 
muscle, Notch regulates proliferation and myogenic commit-
ment of activated SCs (Nye et al., 1994; Kopan et al., 1994; 
Kuroda et al., 1999; Conboy and Rando, 2002; Luo et al., 2005; 
Holterman et al., 2007). Recent data have shown a role for 
Notch in asymmetric SC division (Shinin et al., 2006; Kuang   
et al., 2007) and myoblast progression through the cell cycle in 
culture (Carlson et al., 2008), as well as a requirement for main-
taining a population of undifferentiated “reserve” cells in cul-
ture (Kitzmann et al., 2006).
Notch  receptors  are  intramolecular  heterodimers  com-
posed of an ectodomain disulfide linked to a transmembrane 
subunit (Shimizu et al., 2002; Fiúza and Arias, 2007). Four 
Notch receptors (Notch1–4) and six Notch ligands (Jagged1 
and -2, Delta1, Delta3 and -4, and X-Delta2) are present in 
mammals (D’Souza et al., 2008). When a Notch receptor inter-
acts with an adjacent Notch ligand or one present on an oppos-
ing cell, the Notch receptor undergoes a sequence of proteolytic 
cleavages that release the Notch intracellular domain (NICD). 
The soluble NICD then translocates to the nucleus, where it 
binds and activates the transcription factor CBF1/suppressor of 
hairless/Lag-1 (CSL), inducing expression of members of the 
Hes and Hey families of basic helix-loop-helix transcription 
factors (Jarriault et al., 1995; Iso et al., 2003). A role for heparan 
sulfates in Drosophila Notch has been postulated (Kamimura   
et al., 2004), but the mechanisms involved are not known, and 
similar results have not been described in mammals. Here, we 
used Ingenuity Pathway Analysis (IPA) of global gene expres-
sion data obtained from Affymetrix arrays comparing changes 
occurring in uninjured versus injured wild-type and sdc3
/ 
SCs to investigate candidate mechanisms responsible for the 
observed sdc3
/ phenotypes. The IPA analysis revealed a re-
duction of Notch target gene expression in sdc3
/ SCs com-
pared with wild-type SCs. We then show an interaction between 
Notch and Syndecan-3 and a requirement for Syndecan-3 in 
Notch processing and signaling. The absence of Syndecan-3 
impairs Notch signaling, altering SC homeostasis and affecting 
skeletal muscle regeneration.
Results
Syndecan-3 loss affects SC proliferation, 
differentiation, and self-renewal in culture
Loss of Syndecan-3 affects SC proliferation, commitment to 
myogenesis, and differentiation (Cornelison et al., 2004), which 
implicates this HSPG as an important component of the SC 
niche. To better understand the effects of Syndecan-3 loss on SC 
proliferation and differentiation, we examined the behavior of 
myofiber-associated SCs in culture explanted from wild-type 
and  sdc3
/  mouse  hindlimb  muscles.  Sdc3
/  SCs  activate 
more rapidly after the myofiber explant, as a greater number of 
BrdU
+ and MyoD
+ SCs are found on sdc3
/ myofibers com-
pared with the wild-type controls, (Fig. 1, A and B). Despite 
their rapid activation, sdc3
/ SCs expand less than wild-type 
cells in culture (Fig. 1 C). This difference is not caused by a dif-
ference in the numbers of proliferating cells, as demonstrated by 
a 4-h BrdU pulse label (unpublished data). However, a short 429 Notch processing requires Syndecan-3 • Pisconti et al.
we observed similar phenotypes in vivo during injury-induced 
muscle regeneration. Injured sdc3
/ tibialis anterior (TA) 
muscles have more BrdU
+ cells (Fig. 2, A and E), fewer P-H3
+ 
cells (Fig. 2, B and F), and increased cell death (TUNEL
+ cells; 
Fig. 2 C, G) compared to wild-type controls 36 h after injury. 
Moreover, similar to our in vitro data, we observe dysregulated 
cell fate choices in vivo (Fig. 2, D and H–J). Injured sdc3
/ 
self-renewal may be responsible for the reduced expansion of 
sdc3
/ cells in culture.
Syndecan-3 loss affects SC proliferation, 
differentiation, and self-renewal in vivo
The effects of Syndecan-3 loss on SC proliferation and differen-
tiation observed in culture are unlikely to be a culture artifact, as 
Figure 1.  Cell cycle progression and cell fate decisions are dysregulated in cultured sdc3
/ SCs. (A and B) Myofiber-associated sdc3
/ SCs exit from 
quiescence and enter the cell cycle faster than wild-type cells. The percentage of BrdU
+ (A) and MyoD
+ (B) SCs is increased on sdc3
/ myofibers at 6 h 
and 12 h after explant compared with wild-type myofibers. (C) Sdc3
/ SCs expand less than wild-type controls during the first 2.5 d in culture (means 
from one representative experiment of four; ≥20 clones/plate scored). (D and E) Explanted and cultured sdc3
/ SCs were pulse-labeled for 30 min with 
10 µM BrdU before fixation and immunostaining to detect BrdU, Syndecan-4 (Sdc4) as a SC marker, and P-H3 to mark mitotic cells. The percentage of 
Sdc4
+BrdU
+ cells normalized to the total number of Sdc4
+ cells is higher (D, n = 5) and the percentage of Sdc4
+P-H3
+ cells is lower (E, n = 3) in sdc3
/ 
SC cultures compared with wild-type controls. (F) Wild-type and sdc3
/ SCs in culture were pulse-labeled with CldU followed by IdU after either a 4-h or 
8-h chase. A higher percentage of sdc3
/ cells were in S phase during both the CldU and the IdU pulses, and were therefore double labeled, compared 
with wild-type cells. (G) Increased cell death is detected by a TUNEL assay in explanted sdc3
/ SC cultures compared with wild-type cultures (n = 3).   
(H) Explanted sdc3
/ SCs fuse into hypertrophic myotubes and generate fewer Sdc4
+/Pax7
+ reserve cells compared with wild-type cultures 48 h after dif-
ferentiation induction. Bars, 10 µm. (I) Quantification of G. Pax7
+Sdc4
+ mononuclear cells normalized to total Sdc4
+ mononuclear cells (15 clones/sample; 
n = 3). Open bars, wild type; shaded bars, sdc3
/. Error bars indicate SEM. **, P < 0.01; *, P < 0.05.JCB • VOLUME 190 • NUMBER 3 • 2010   430
Figure 2.  Cell cycle progression and cell fate decisions are dysregulated in regenerating sdc3
/ muscles in vivo. (A–G) Proliferation is impaired in 
sdc3
/ SCs. Sections from wild-type TA muscles show fewer BrdU
+ cells (arrows in A indicate BrdU
+ cells; E shows a quantification of A), more P-H3
+ cells 
(arrows in B indicate P-H3
+ cells; F shows a quantification of B), and fewer TUNEL
+ cells (C) than those from sdc3
/ TA muscles (G shows a quantification 
of C). (D and J) Cell fate decisions are altered in sdc3
/ SCs. The number of Pax7
+ sublaminar cells (SCs) per tissue area is reduced (arrows in D indicate 
Pax7
+ cells; H shows a quantification of D), the myofiber cross-sectional area is increased (I), and the total number of myofibers per tissue area is reduced 
(J) in sdc3
/ TA muscles 3 mo after injury compared with wild-type muscles. Medians of the myofiber cross-sectional area distribution for each genotype at 
3 mo after injury are shown in I. Curves in I represent polynomial functions that best fit the plotted myofiber size distributions; broken line, wild type; solid 
line, sdc3
/. A minimum of 1,000 myofibers and four sections per each biological replica were scored. Inset panels in B–D show enlarged views of the 
boxed regions. Open bars, wild type; shaded bars, sdc3
/. Error bars indicate SEM. **, P < 0.01. Bars, 30 µm.431 Notch processing requires Syndecan-3 • Pisconti et al.
TA muscles show fewer Pax7
+ SCs when analyzed at 2 wk,   
6 wk (Fig. S2), or 3 mo (Fig. 2, D and H) after injury, and an in-
crease in myofiber size at 3 mo after injury when compared with 
wild-type controls (Fig. 2 I). This is accompanied by a decrease 
in the myofiber number (Fig. 2 J). Although the total number 
of nuclei per tissue area is unchanged in sdc3
/ regenerated 
TA muscles compared with wild-type controls (not depicted), 
more of the sdc3
/ nuclei are found in hypertrophic myofibers, 
whereas fewer cells are retained as undifferentiated Pax7
+ pro-
genitors (Fig. 2, D and H). Our in vitro and in vivo results in-
dicate that loss of Syndecan-3 impairs SC progression through 
the cell cycle and alters cell fate choices, leading to myofiber 
hypertrophy and depletion of the undifferentiated (sublaminar, 
Pax7
+) population upon muscle injury.
Syndecan-3 is required for Notch signaling
Genetic ablation of Syndecan-3 leads to alterations in several 
signaling pathways involved in the regulation of adult myogen-
esis, but the molecular mechanisms involved are unknown 
(Cornelison et al., 2004). To identify the mechanisms involved, 
we used a global gene expression analysis approach. SCs were 
FACS-isolated from wild-type, sdc3
/ uninjured, and injured 
TA muscles 12 h after injury. Gene expression was then ana-
lyzed using Spotfire software after hybridization to Affymetrix 
gene chips, where we investigated which genes were up-regulated 
by ≥1.5-fold in wild-type SCs 12 h after injury but were not   
up-regulated in sdc3
/ SCs 12 h after injury (Table S1).   
Relative expression of Notch target genes appeared impaired in 
sdc3
/ versus wild-type SCs isolated 12 h after an induced 
muscle injury (Fig. 3 A). The Notch pathway is a key regulator 
of adult myogenesis, where Notch inhibition leads to reduced 
muscle progenitor cell proliferation (Conboy and Rando, 2002; 
Carlson et al., 2008), precocious terminal differentiation and   
fusion (Conboy and Rando, 2002; Holterman et al., 2007), and 
reduced progenitor self renewal (Kitzmann et al., 2006; Kuang 
et al., 2007). Remarkably, these are all phenotypes we observe 
in sdc3
/ SCs in vitro (Fig. 1) and in vivo (Fig. 2).
12 h after injury, expression of Notch target genes is re-
duced in sdc3
/ SCs compared with wild-type SCs (Fig. 3 A). 
Similarly,  cultured  sdc3
/  SCs  fail  to  activate  the  Notch   
reporter Hes1-Luc (Fig. 3 B). Furthermore, the basal reporter 
activity observed in sdc3
/ cells is not affected by treatment 
with  the  Notch  inhibitor  N-[N-(3,5-difluorophenacetyl)-l-
alanyl]-(S)-phenylglycine  t-butyl  ester  (DAPT;  Fig.  3  B).   
In agreement with these data, sdc3
/ SCs have reduced levels 
of Hes1 protein compared with their wild-type counterpart   
(Fig. 3 C). We obtained similar results when we used a dif-
ferent Notch reporter, CSL-Luc, which suggests that Notch 
signaling is inhibited in sdc3
/ SCs upstream of Notch target 
transcription (Fig. S3 A).
Inhibition of Notch signaling due to Syndecan-3 loss is 
not  caused  by  reduced  receptor  expression,  as  Notch1  and 
Notch2 mRNA levels in cultured sdc3
/ SCs are comparable 
to levels in wild-type cells (Fig. S3 B). Reduction of Notch sig-
naling in sdc3
/ SCs is directly due to Syndecan-3 loss be-
cause ectopic expression of Syndecan-3 in sdc3
/ SCs rescues 
activation of the Notch reporter CSL-Luc (Fig. 3 D). Similarly, 
knockdown  of  Syndecan-3  in  the  SC  line  MM14  (Lim  and 
Hauschka, 1984) by transfection with a mix of three different 
Syndecan-3 siRNAs reduces activation of both Hes1-Luc and 
CSL-Luc Notch reporters (Fig. 3, E and F).
Molecular events that link Syndecan-3  
to Notch
Expression levels of Notch targets are reduced in sdc3
/ SCs 
activated by induced muscle injury compared with wild-type 
controls (Fig. 3 A). To identify components of the Notch path-
way that may account for the lack of Notch signaling in sdc3
/ 
SCs, we compared global gene expression in wild-type and 
sdc3
/ SCs isolated from uninjured TA muscles with SCs iso-
lated from injured TA muscles 12 h after injury using IPA. IPA 
provided two appealing candidates: (1) Notch ligands (Delta/
Jagged), induced in wild-type but not in sdc3
/ SCs upon in-
jury, and (2) the Notch inhibitor Numb, which was induced in 
sdc3
/ but not in wild-type cells upon injury (Fig. 4 A).
To  evaluate  SC  responsiveness  to  Notch  receptor  stimu-
lation, we cultured wild-type and sdc3
/ SCs on tissue culture 
plates coated with an activating anti-Notch1 antibody that mim-
ics ligand activation of Notch1 (anti-Notch1, clone 8G10; Conboy   
et al., 2003). Culture of sdc3
/ cells with the activating anti-
Notch1 antibody fails to increase expression of either Hes1   
(Fig. 4 B) or Hey2 (Fig. S4 A). Moreover, the expression of these 
two Notch targets is reduced in untreated sdc3
/ SCs compared 
with untreated wild-type cells, which confirms the Notch reporter 
activities (Figs. 4 B and S4 A). The reduction in Notch target gene 
induction  was  accompanied  by  impaired  NICD  accumulation 
(Fig. 4 C) and nuclear localization (Fig. 4 D) in sdc3
/ versus 
wild-type cultured SCs. Similar results where obtained when TA 
muscle sections were analyzed for Notch1 intracellular domain 
localization in SCs 24 h after injury (Fig. S4 B). Thus, all of our 
in vitro and in vivo data suggest that reduced NICD is responsible 
for reduced Notch signaling in sdc3
/ SCs.
Decreased  levels  of  NICD  in  sdc3
/  cells  could  be 
caused by impaired signal transduction or by a reduction in 
NICD  stability.  Nuclear  NICD  is  a  very  short-lived  protein 
(Chiba, 2006). Cofactors of the Mastermind family (MAML) 
and the hypoxia responding factor 1 (HIF1-) directly inter-
act with the CSL-NICD transcription activation complex and 
regulate NICD turnover (Keith and Simon, 2007; McElhinny et al.,   
2008). Culturing cells in a low oxygen atmosphere activates 
HIF1- and stabilizes nuclear NICD, enhancing Notch signal-
ing in primary SCs and myoblast cell lines (Gustafsson et al., 
2005). Enhanced Notch signaling prevents differentiation and 
promotes expansion of undifferentiated myoblasts (Gustafsson   
et al., 2005; Keith and Simon, 2007). If the impaired NICD ac-
cumulation observed in sdc3
/ SCs is caused by reduced NICD 
stability, we predict that culturing under low oxygen will res-
cue Notch signaling in sdc3
/ cells to wild-type levels. Al-
though capable of increasing Hes1 protein levels and Notch 
reporter activation in wild-type cells, culturing sdc3
/ cells 
in low oxygen failed to rescue Hes1 protein levels (Fig. 4 E)   
and Notch reporter activation (Fig. S4 C). Thus, we conclude 
that impaired NICD generation rather than reduced NICD sta-
bility  is  likely  the  primary  cause  of  impaired  Notch  signaling JCB • VOLUME 190 • NUMBER 3 • 2010   432
in  sdc3
/  SCs  also  rescued  reduced  myoblast  expansion   
(Fig. 4 G), impaired cell cycle progression (Fig. 4, H and I), 
and rescued SC self-renewal (Fig. 4 J). Culture in low oxygen 
atmosphere only partially rescued sdc3
/ myoblast expansion 
in sdc3
/ SCs. Indeed, ectopic expression of a wild-type 
NICD containing the PEST domain that is responsible for its 
short half-life completely rescues Notch reporter activation in 
sdc3
/ SCs (Fig. 4 F). Furthermore, NICD ectopic expression   
Figure 3.  Notch signaling is impaired in the absence of Syndecan-3 and rescued by ectopic Syndecan-3 expression. (A) Wild-type and sdc3
/ SCs were 
FACS-isolated from uninjured TA muscles and TA muscles 12 h after injury, then total mRNA was extracted and pooled from a minimum of three animals, 
and gene expression was assayed on three replicate Affymetrix gene chips. Relative gene expression (false discovery rate ≤ 0.01; P ≤ 0.01) and expres-
sion levels of several Notch target genes were plotted. (B) Notch reporter activity is increased in wild-type compared with sdc3
/ cultured SCs and reduced 
by DAPT treatment in wild-type but not sdc3
/ SCs (n = 8). (C) The number of Hes1
+ cells is reduced in proliferating sdc3
/ SC cultures compared with 
wild-type cultures. Syndecan-4 (Sdc4) marks all SCs (n = 3). Bars, 10 µm. (D) Ectopic expression of Syndecan-3 (sdc3) in sdc3
/ SCs restores Notch 
reporter activity to wild-type levels. (E) Syndecan-3 knockdown reduces Notch reporter activity in MM14 cells. (E, inset) Syndecan-3 siRNAs (S3 siRNA) 
reduce Syndecan-3 mRNA. (F) The extent of Syndecan-3 knockdown reflects the efficiency of transfection and is proportional to the extent of Notch reporter 
activity reduction. GFP
+ MM14 cells transfected with EGFP and Syndecan-3 siRNAs or scrambled siRNAs as indicated were harvested 24 h after transfec-
tion. Total mRNA was extracted from unsorted or GFP
+ FACS–sorted cells, quantitative PCR (q-PCR) for Syndecan-3 and 18S was performed, and values 
for Syndecan-3 mRNA, normalized to 18S ribosomal mRNA, were plotted (n = 2). Open bars, wild type; shaded bars, sdc3
/. Error bars indicate SEM. 
**, P < 0.01; #, P > 0.05.433 Notch processing requires Syndecan-3 • Pisconti et al.
Syndecan-3 regulates Notch  
signal transduction
A defect in NICD generation may be caused by defective 
Notch receptor activation and processing or may be caused by 
inhibition of Notch signal transduction (Kopan et al., 1996; 
(Fig. S4 D) and did not rescue the impaired cell cycle progres-
sion or self-renewal (not depicted). These results demonstrate 
that reduced NICD stability is not responsible for the reduced 
Notch signaling observed in sdc3
/ SCs but instead suggest a 
role for Syndecan-3 in NICD generation.
Figure 4.  Syndecan-3 is required for NICD generation. (A) Results from IPA analysis of genes differentially expressed in SCs from 12-h injured TA muscles 
versus uninjured TA muscles are shown for both wild-type (left) and sdc3
/ (right) mice: the intensity of the red color depicted in the figure is proportional 
to the relative increase in gene expression in SCs at 12 h after injury versus uninjured. Sdc3
/ SCs induce Numb at a higher extent than wild-type SCs and 
fail to induce Notch ligands and several Notch target genes in response to injury. (B) Sdc3
/ SCs fail to induce Hes1 mRNA when stimulated with an anti-
Notch1 antibody. SCs cultured for 48 h on plates coated with a stimulating anti-Notch1 antibody were assessed by q-PCR for Hes1 mRNA (18S ribosomal 
RNA was used as a loading control; n = 3). (C) Western blot analysis for NICD of wild-type and sdc3
/ SCs cultured as in B shows that NICD is reduced in 
sdc3
/ SC extracts compared with wild-type cell extracts, and does not increase in response to Notch1 stimulation. Anti-tubulin is shown as a loading control.   
(D) Subcellular localization of Notch1 probed with an antibody specific to the intracellular domain of Notch1 reveals nuclear and extranuclear localization 
in wild-type SCs, but only extranuclear localization in sdc3
/ SCs. Bars, 10 µm. (E) Western blot analysis of Hes1 shows that Hes1 protein levels are 
reduced in sdc3
/ SC extracts compared with wild-type extracts and are not rescued by culturing the cells under low oxygen atmosphere. Molecular mass 
standards are indicated next to gel blots (kD). (F) CSL-Luc reporter activity is enhanced in wild-type and rescued in sdc3
/ SCs expressing the NICD (n = 3).   
(G) Ectopic expression of NICD rescues sdc3
/-reduced expansion in culture. Wild-type and sdc3
/ SCs transfected with eGFP and either an empty 
vector (control) or NICD (NICD) were scored for the total number of GFP
+ cells/clone 48 h after transfection (20 clones/plate scored, n = 3). (H–J) Ectopic 
expression of NICD rescues sdc3
/ cell cycle and cell fate phenotypes. Wild-type and sdc3
/ cultured SCs were transfected as in G. 48 h after transfec-
tion, they were scored for the number of GFP
+BrdU
+ cells (H), GFP
+P-H3
+ cells (I), or GFP
+Pax7
+ cells (J). Values normalized to the total number of GFP
+ cells 
are plotted (n = 3). Open bars, wild type; shaded bars, sdc3
/. Error bars indicate SEM. **, P < 0.01; *, P < 0.05; #, P > 0.05.JCB • VOLUME 190 • NUMBER 3 • 2010   434
accumulated more in sdc3
/ than in wild-type cells, which 
supports a role for Syndecan-3 in promoting N
TM processing by 
TACE (Fig. 5 C, lanes 1 and 2). In contrast, we found equal ac-
cumulation of E and NICD upon ectopic expression of either 
E-6mt or ICV-6mt (Fig. 5 C, lanes 3–6), which indicates that 
E-6mt processing by -secretase and ICV-6mt stability are not 
affected by Syndecan-3 loss. The additional band running at a 
lower molecular weight in the sdc3
/ extracts transfected with 
E-6mt (Fig. 5 C, lane 4) does not correspond to NICD gen-
erated by cleavage of E-6mt, as only ectopically expressed 
ICV-6mt was detected by the anti-NICD antibody (Val-1744) 
that specifically recognizes NICD upon -secretase–mediated 
cleavage (Fig. 5 C). These results strongly support our hypoth-
esis involving Syndecan-3 in regulating TACE-mediated cleav-
age of Notch at the S2 site.
To further investigate the involvement of Syndecan-3 in 
Notch processing at the S2 site, we transfected wild-type and 
sdc3
/ SCs with N
FL-6mt, and quantified N
TM accumulation 
upon treatment with either a -secretase inhibitor (DAPT) 
or  a TACE  inhibitor  (TIMP-3). TIMP-3  treatment  rescued 
the difference in N
TM accumulation between wild-type and 
sdc3
/ cell extracts (Fig. 5 D, lanes 5 and 6 vs. lanes 1 and 2),   
whereas  DAPT  treatment  was  ineffective  at  altering  the   
levels of either wild-type or sdc3
/ N
TM (Fig. 5 D, lanes 3 
and 4 vs. lanes 1 and 2). Furthermore, we found that E-6mt 
ectopic  expression  yielded  equivalent  E  band  intensities 
in both nontreated and DAPT-treated wild-type and sdc3
/ 
cells  (Fig.  S5  C).  These  data  further  support  our  hypoth-
esis for the involvement of Syndecan-3 in Notch processing 
by ADAM17/TACE and rule out a role for Syndecan-3 in   
-secretase–mediated cleavage.
Syndecan-3 and Notch are present in a 
complex on the SC plasma membrane
A requirement for Syndecan-3 in Notch processing suggests 
that Syndecan-3 and Notch may interact. Notch1 (N
FL-6mt) 
Logeat et al., 1998; Schroeter et al., 1998; Brou et al., 2000; 
Mumm et al., 2000). An analysis of gene expression data by 
IPA suggests that increased Numb expression is a possible can-
didate for inhibition of Notch signal transduction (Fig. 4 A). 
Cultured sdc3
/ SCs show dramatically increased levels of 
Numb compared with wild-type cells, which confirms our   
microarray data (Fig. 5 A). However, high levels of Numb ap-
pear to affect sdc3
/ cells in a Notch-independent manner, as 
increased Numb levels but not impaired Notch signaling are 
reversed by low oxygen (compare Fig. 5 A with Fig. 4 E). Thus, 
increased Numb levels cannot account for the loss of Notch 
target gene induction in sdc3
/ cells, and this finding supports 
a hypothesis involving Syndecan-3 in regulating Notch recep-
tor processing after ligand binding.
Upon ligand binding, Notch signaling is initiated by two 
proteolytic cleavages of Notch (Fig. S5 A). The first cleavage 
at the S2 site occurs in the extracellular domain and is mediated 
by the matrix metalloproteinase ADAM17/TNF-converting   
enzyme (TACE). The second cleavage at the S3 site occurs within 
the plasma membrane and is mediated by the -secretase 
complex (Fig. S5 A). To understand which Notch processing 
event is affected by loss of Syndecan-3, we used three dif-
ferent deletion mutants of Notch: (1) N
FL-6mt, a mutant that   
signals  in  a  ligand-independent,  TACE-  and  -secretase– 
dependent manner; (2) E-6mt, a mutant that requires only   
-secretase–mediated cleavage to signal; and (3) ICV-6mt, a 
mutant that is constitutively active (Fig. S5 B). In each of these 
three mutants, the PEST domain has been replaced by a 6-myc 
epitope tag, stabilizing the protein and providing detection of 
the exogenous Notch mutants. When cotransfected with a Notch 
reporter, ICV-6mt and E-6mt, but not N
FL-6mt, rescue Notch 
signaling in sdc3
/ SCs (Fig. 5 B), which suggests a role for 
Syndecan-3 in regulating TACE-mediated cleavage of Notch at 
the S2 site (Fig. S5 A). When wild-type and sdc3
/ SCs trans-
fected with N
FL-6mt were analyzed by Western blotting, the 
transmembrane Notch fragment before TACE cleavage, N
TM, 
Figure  5.  Syndecan-3  is  involved  in  Notch 
processing  by  ADAM17/TACE.  (A)  Numb 
protein  levels  are  increased  in  sdc3
/  SCs 
analyzed by Western blotting and rescued to 
wild-type levels by exposure to low oxygen. 
Ponceau staining is shown as a loading control. 
(B) Explanted wild-type and sdc3
/ SCs were 
transfected  with  N
FL-6mt,  E-6mt,  or  ICV-6mt   
in addition to either empty vector or CSL-Luc 
and  CMV-LacZ  as  a  transfection  efficiency 
control. Reporter activity analyzed 24 h after 
transfection revealed that E-6mt and ICV-6mt, 
but  not  N
FL-6mt,  ectopic  expression  rescues 
Notch reporter activity in sdc3
/ SCs to wild-
type  levels.  (C)  Wild-type  and  sdc3
/  SCs 
were isolated, cultured, and transfected as in B.   
24 h later, they were analyzed by Western 
blotting to detect the myc-tag epitope. Ectopic 
Notch1  accumulates  in  sdc3
/  cells  trans-
fected with N
FL-6mt (N
TM), but not in sdc3
/ 
cells transfected with either E-6mt or ICV-6mt (n = 3). The same blot was stripped and reprobed to detect NICD generated by -secretase cleavage.   
Although NICD was detected in samples transfected with ICV-6mt, no NICD was detected upon N
FL-6mt or E-6mt ectopic expression (n = 2). -galactosidase   
is shown as a loading control. (D) Explanted wild-type and sdc3
/ SCs transfected with N
FL-6mt were treated as indicated 24 h after transfection. Western 
blots of cell lysates were probed for the myc-tag epitope and -galactosidase. N
TM band intensities were quantified and values were normalized to the cor-
responding -galactosidase band intensities plotted, with the normalized value corresponding to wild-type nontreated cells set at 1. Open bars, wild type; 
shaded bars, sdc3
/. Error bars indicate SEM. *, P < 0.05; #, P > 0.05. Molecular mass standards are indicated next to gel blots (kD).435 Notch processing requires Syndecan-3 • Pisconti et al.
Our coimmunoprecipitation results strongly support a hypoth-
esis for a specific Syndecan-3/Notch interaction. If Syndecan-3 
and  Notch  coexist  in  the  same  molecular  complex  where   
Syndecan-3 facilitates Notch processing by TACE, we expect 
to find an increased abundance of Notch in immunocomplexes 
precipitated by an anti–Syndecan-3 antibody when Notch pro-
cessing is inhibited. We also expect reduced Notch abundance in   
immunoprecipitated complexes when Notch processing is pro-
moted. As expected, the abundance of Notch in anti–Syndecan-3   
immunoprecipitates decreases when Notch processing is stimu-
lated by an anti-Notch1–activating Ab, and increases when 
Notch processing is inhibited by TIMP-3 (Fig. 6 B). We were 
unsuccessful at attempts to coimmunoprecipitate endogenous 
ectopically  expressed  in  MM14  cells  coimmunoprecipitates   
with  Syndecan-3  (Fig.  6 A,  lane  1),  which  suggests  that   
Syndecan-3 and Notch may physically interact. The disperse 
Syndecan-3 protein band (Fig. 6 A) is indicative of the incomplete 
GAG chain removal by heparitinase digestion required before 
gel electrophoresis (see Materials and methods). Increasing the 
stringency  of  washes  after  Syndecan-3  immunoprecipitation 
did not affect the ratio of Notch/Syndecan-3 coimmunoprecipi-
tated (unpublished data), which indicates that the interaction 
between  Syndecan-3  and  Notch  is  specific.  The  amount  of 
coimmunoprecipitated Notch1 increases when Syndecan-3 is 
overexpressed (Fig. 6 A, lane 2), and is undetectable when cells 
are cotransfected with Syndecan-3 siRNA (Fig. 6 A, lane 4).   
Figure 6.  Syndecan-3 and Notch are in a complex on the SC membrane. (A) Syndecan-3 and Notch1 (N
FL-6mt) were coimmunoprecipitated from MM14 
cell extracts with an anti–Syndecan-3 antibody 24 h after transfection, and Western blots were probed for the myc-tag epitope and for Syndecan-3 using 
a terminal heparan sulfate attachment antibody (-HS). (B) Extracts from MM14 cells cultured in the presence or absence of an anti-Notch1 antibody, 
transfected as in E, and treated with or without 200 nM TIMP-3 were immunoprecipitated with an anti–Syndecan-3 antibody. Blots probed for the myc-tag 
epitope, then stripped and reprobed for -HS. The relative levels of N
TM were quantified and plotted with the level of N
TM in the untreated sample set to 1.   
Molecular mass standards are indicated next to gel blots (kD). (C–F) Endogenous Notch and Syndecan-3 are present in a protein complex on the SC 
surface, as revealed using DuoLink with an extracellular anti-Notch1 antibody and an intracellular Syndecan-3 antibody. Two distinct Notch1 antibodies 
from different species show as positive complexes in Syndecan-4 (sdc4)
+ cells (green) after DuoLink labeling (C, red), whereas elimination of the primary 
anti-Notch1 and anti–Syndecan-3 antibodies yielded no positive complexes (D). Endogenous Notch1 and Syndecan-3 appear as complexes (red dots) in 
wild-type Syndecan-4
+ cells (E) but are absent or at background levels in sdc3
/ cells (E). Arrows indicate which cells are magnified in the inset panels. 
(F) Quantification of C–E, where the mean number of DuoLink
+ complexes/cell is plotted. n = 3. Open bars, wild type; shaded bars, sdc3
/. Error bars 
indicate SEM. **, P < 0.01; #, P > 0.05. Bars, 10 µm.JCB • VOLUME 190 • NUMBER 3 • 2010   436
investigated. We demonstrated an interaction between Syndecan-3 
and Notch1 with a PLA in SCs, and by dose-dependent coimmuno-
precipitation of both proteins that is further supported by the 
observation that the amount of Notch coimmunoprecipitated 
with Syndecan-3 varies when Notch processing is inhibited or 
promoted.  Syndecan-3  appears  to  facilitate  TACE-mediated 
cleavage of Notch, a key step in Notch signaling transduction 
upon ligand binding. Because the molecular mechanisms re-
sponsible for heparan sulfate–mediated regulation of signaling 
pathways often involves direct interaction of the HSPG GAG 
chains with either growth factors or their cognate receptors 
(Bass et al., 2009), we asked if the glycosaminoglycan chains, 
the core protein of Syndecan-3, or both were involved in regu-
lating  Notch  signaling.  Elimination  of  sulfation  by  chlorate 
treatment reduces Notch reporter activity, which supports the 
involvement of HSPG GAG chains; however, Notch reporter 
activity in sdc3
/ cells cannot be rescued by exogenous hepa-
rin (unpublished data). Our data demonstrate an important role 
for Syndecan-3 in regulating SC fate that is in part mediated via 
Notch signaling, where both the GAG chains and the core pro-
tein appear to play key roles.
Syndecan-3 and Notch are components of the SC niche. 
The finding that Syndecan-3 promotes Notch processing and 
signaling represents a further step toward understanding the 
mechanisms that regulate SC niche function. In this scenario, 
the Syndecan-3–Notch interaction seems to play important roles 
in the regulation of SC proliferation, commitment to terminal 
differentiation, and self-renewal. We tested this possibility and 
found that Syndecan-3 regulates the balance between SC pro-
liferation, differentiation, and self-renewal. In the absence of 
Syndecan-3, SCs progress more slowly through S phase, lead-
ing to reduced progenitor cell expansion, delayed onset of dif-
ferentiation, and increased cell death in addition to reduced 
self-renewal. Because constitutive activation of Notch signaling 
in sdc3
/ SCs rescues the altered cell cycle progression and 
impaired self-renewal, we postulate that Syndecan-3 and Notch 
cooperate in regulating cell cycle progression and cell fate de-
termination of SCs.
Little is known to date regarding the possible mechanisms 
whereby Notch directly regulates SC proliferation (Gustafsson 
et al., 2005; Carlson et al., 2008). Notch signaling is known to 
inhibit myogenic differentiation, and, thus has been proposed 
to indirectly promote expansion of undifferentiated progenitors 
(Luo et al., 2005). However, recent work describes a role for 
Notch signaling in antagonizing TGF-–dependent activation 
of the cyclin-dependent kinase inhibitors including p15, p16, 
p21, and p27 (Carlson et al., 2008). Because p21 and p15 play 
a key role in regulating intra–S phase checkpoints in a TGF-– 
dependent manner in other progenitor cells (Zhu et al., 2004; 
Jirmanova et al., 2005; Kan et al., 2007; Petrov et al., 2008), 
it is possible that p15 and p21 regulate intra–S phase check-
points in SCs as well. We believe that inhibition of Notch sig-
naling in SCs, either because of an aged environment (Conboy 
et al., 2003; Carlson et al., 2008) or Syndecan-3 loss, results in   
increased expression of intra–S phase checkpoint inhibitors (in-
cluding p15 and p21), leading to delayed progression through 
S-phase, increased cell doubling times, reduced cell survival, 
Notch1 and Syndecan-3 in SCs using combinations of five   
different antibodies (unpublished data). However, using the 
DuoLink technology, an in situ proximity ligation assay (PLA) 
that detects two proteins only when they are in close proximity, 
we were able to demonstrate that Notch1 and Syndecan-3 are 
present in a complex on the SC plasma membrane. A positive 
control using two anti-Notch1 antibodies that recognize dis-
tinct epitopes was visualized as DuoLink complexes (red) in 
Syndecan-4
+ cells (Fig. 6 C), whereas elimination of primary 
anti-Notch  and  anti–Syndecan-3  antibodies  revealed  few  or 
no complexes (Fig. 6 D). If wild-type cells are processed for 
DuoLink using an extracellular anti-Notch1 antibody and an   
intracellular  anti–Syndecan-3  antibody,  abundant  complexes 
are present (Fig. 6 E, left) that are absent in sdc3
/ cells (Fig. 6 E, 
right). The number of DuoLink reaction products was quanti-
fied, demonstrating the presence of abundant Notch1–Syndecan-3 
complexes only in wild-type cells (Fig. 6 F). These data support 
the hypothesis that Syndecan-3 and Notch interact in a molecu-
lar complex involved in Notch processing.
Discussion
HSPGs play critical roles in regulating growth factor signaling 
pathways via a variety of mechanisms, including coreceptor 
functions, ligand sequestration, morphogenetic boundary regu-
lation, and stem cell fate determination (Rapraeger et al., 1991; 
Lander, 1998; Muñoz et al., 2006; Dombrowski et al., 2009). 
Syndecan-3, a transmembrane HSPG expressed in adult SCs, 
has been previously described as playing a role in adult myo-
genesis  (Fuentealba  et  al.,  1999;  Cornelison  et  al.,  2001; 
Cornelison et al., 2004), but the mechanisms involved remain 
poorly understood. An in-depth characterization of sdc3
/ pheno-
types in vitro and in vivo, combined with an unbiased analysis 
of gene expression and signaling, have allowed us to further ex-
plore the mechanisms involved in Syndecan-3–mediated reg-
ulation of adult myogenesis.
To identify signaling pathways contributing to the sdc3
/ 
phenotype, we performed a global gene expression analysis com-
paring wild-type and sdc3
/ SCs in uninjured muscle and 12 h 
after injury. IPA analysis of the gene expression data revealed a 
failure to induce Notch targets in sdc3
/ cells upon muscle in-
jury and an increase in Numb expression. The increase in Numb 
expression could potentially account for the loss of Notch signal-
ing, as Numb targets Notch for degradation by the proteasome 
(McGill and McGlade, 2003). In cultures under low oxygen at-
mosphere, we observed reduced Numb protein in sdc3
/ SCs 
but no rescue of Notch signaling, which suggests that increased 
Numb levels are unlikely to be responsible for impaired Notch 
signaling in sdc3
/ SCs. Instead Numb may function in SCs in 
a Notch-independent manner, similar to the role recently reported 
for Numb in embryonic myogenesis (Jory et al., 2009).
Proteoglycans are involved in binding and signaling for   
at least 200 secreted factors, often interacting with the proteo-
glycan GAG chains (Bass et al., 2009). Despite a prior publica-
tion postulating a role for a heparan sulfate 3-O-sulfotransferase 
in Drosophila Notch signaling (Kamimura et al., 2004), a re-
quirement for proteoglycans in Notch signaling has not been   437 Notch processing requires Syndecan-3 • Pisconti et al.
Notch signaling on later stages of muscle regeneration have not 
been tested (Conboy et al., 2003; Brack et al., 2008; Smythe 
et al., 2008; Carlson et al., 2009). Therefore we investigated 
muscle regeneration in sdc3
/ mice at 2 wk, 6 wk, and 3 mo 
after injury. Despite the impaired SC function we observed at 
early stages of muscle regeneration, which was similar to that 
observed in old injured muscles (Carlson et al., 2008), muscle 
regeneration in sdc3
/ mice was not impaired 3 mo after injury. 
Instead, as predicted from the cell cycle and cell fate pheno-
types  of cultured  sdc3
/ SCs, regenerated  sdc3
/ muscles 
display phenotypes consistent with a severe imbalance in cell 
fate decisions. Sdc3
/ cells prefer to differentiate as opposed to 
self-renew, creating an imbalance that gives rise to abnormally 
large myofibers accompanied by a reduction in the numbers of 
Pax7
+ SCs. Although SC death is increased and self-renewal 
and ultimately reduced SC proliferation (Fig. 7; Carlson et al., 
2008). Our results expand on previous studies, providing ad-
ditional mechanistic insights into roles for Notch signaling in 
regulating SC proliferation (Fig. 7). Furthermore, our data pro-
vide evidence that regulation of the cell cycle directly impacts 
regulation of SC fate decisions, including commitment to termi-
nal differentiation and cell death. Both the increased cell death 
and the delayed differentiation onset we observed are likely to 
be a direct consequence of aberrant progression through intra– 
S phase checkpoints, leading to cell cycle arrest and death, or 
delaying cell cycle exit and therefore the onset of terminal dif-
ferentiation (Fig. 7; Carlson et al., 2008).
A  reduction  in  Notch  signaling  in  aged  mice  leads  to   
aberrant SC function and severely affects muscle regeneration   
5 d after muscle injury, but the effects of a reduction or loss of 
Figure 7.  A model predicting SC behavior in sdc3
/ muscles. (A) In wild-type SCs, Syndecan-3 and Notch reside in a complex where Syndecan-3 fa-
cilitates Notch processing and NICD generation. Quiescent SCs (yellow cells) are activated and commit to myogenesis (green cells), where cooperation 
between Syndecan-3 and Notch promotes cell cycle progression and self-renewal, and inhibits terminal differentiation (red cells) and fusion to existing 
myofibers. Once muscle repair is completed, SCs cease proliferation and undifferentiated cells return to a quiescent state. Repaired myofibers appear 
indistinguishable from uninjured myofibers. (B) In sdc3
/ SCs, Notch processing is impaired and NICD generation is dramatically reduced. Once sdc3
/ 
SCs are activated and commit to myogenesis, the lack of Syndecan-3 and Notch signaling impairs cell cycle progression, delays onset of terminal dif-
ferentiation, and reduces SC self-renewal. Activated sdc3
/ SCs fail to return to quiescence but remain in an activated state that leads to myofiber hyper-
trophy. An increase in cell death and the lengthening of cell cycle progression contribute in maintaining constant the total number of nuclei per tissue area. 
However, the balance between terminal differentiation and self-renewal is disrupted in sdc3
/ regenerating muscles, whereby more nuclei are found in 
hypertrophic myofibers and less in mononucleated sublaminar Pax7
+ cells (SCs). Notch-independent Syndecan-3-dependent signaling pathways are not 
depicted in this diagram.JCB • VOLUME 190 • NUMBER 3 • 2010   438
CEL  files  from  three  biological  replicates  on  three  gene  chips  were   
imported directly into Spotfire (Invitrogen) and normalized by GeneChip 
robust multiarray averaging. Analysis of variance (ANOVA) analysis set 
at a false discovery rate of 0.05% was used to identify differentially ex-
pressed probe sets. Probe sets with ≥1.5-fold changes between uninjured 
and 12-h injured in wild-ype and sdc3
/ datasets were further analyzed 
using IPA. Signaling pathways were analyzed first for pathways that ex-
hibited significant changes between wild-type SCs from uninjured and 
12-h injured muscles. These differences were then compared with signal-
ing pathways in the uninjured versus 12-h injured dataset from sdc3
/ 
SCs. These data were plotted for the Notch pathway with the intensity of 
red signifying the fold change in gene expression.
Reagents
DAPT was obtained from EMD. Cell culture media was obtained from Sigma-
Aldrich. Horse serum was obtained from HyClone. Syndecan-3 siRNA mix 
was obtained from Santa Cruz Biotechnologies, Inc., and RNA-induced si-
lencing complex (RISC)-free control siRNA was obtained from Thermo Fisher 
Scientific. Recombinant tissue inhibitor of metalloproteinases-3 (TIMP-3) puri-
fied from transfected BHK cells was obtained from Abcam.
Cell treatments
For DAPT treatment, cells were incubated for 6–8 h with 10 µM DAPT or 
DMSO (untreated control) before harvesting. For TIMP-3 treatment, cells 
were detached using collagenase, resuspended in either GM alone or GM +   
TIMP-3 at 200 nM, and incubated for 40 min at 37°C before harvest.
Plasmids, transfections, and reporter assays
Hes1-Luc and CSL-Luc constructs were provided by N. Ahn (University of 
Colorado at Boulder, Boulder, CO) and used at 0.5 µg/ml. NICD, N
FL-6mt, 
E-6mt, and ICV-6mt constructs were provided by R. Kopan (Washington 
University, St. Louis, MO) and used at 50 ng/ml, except for N
FL-6mt, which 
was used at 100 ng/ml. The Syndecan-3 (sdc3) expression vector was 
provided by A. Rapraeger (University of Wisconsin, Madison, WI) and 
used at 300 ng/ml. For reporter assays, primary SCs and MM14 myo-
blasts were cultured on gelatin-coated 12-well plates (Corning) and trans-
fected  using  the  Lipofectamine  2000  transfection  reagent  (Invitrogen) 
according to the manufacturer’s instructions. Cells were lysed 24 h after 
transfection. A total of 1 µg/ml of DNA was transfected using an empty 
pGL2basic plasmid as a carrier when required. The CMV-LacZ expression 
vector (0.025 µg/ml) was cotransfected to normalize for transfection effi-
ciency. For Syndecan-3 knockdown experiments, a mix of three different 
Syndecan-3 siRNAs (Santa Cruz Biotechnologies, Inc.) was transfected at 
200 nM in MM14 cells using Lipofectamine 2000 transfection reagent   
(Invitrogen). RISC-free siRNA were used as controls (Thermo Fisher Scien-
tific).  Luciferase  and  -galactosidase  activities  were  determined  as  de-
scribed previously (Olguin et al., 2007). For cell cycle and self-renewal 
rescue, primary SCs were transfected using Lipofectamine 2000 with a 
pEGFP expression vector (0.025 µg/ml) ± NICD; 48 h after transfection, 
coverslips were fixed and immunostained.
Immunofluorescence
Tissue samples, primary SCs, and MM14 cells were prepared as described 
previously (Cornelison et al., 2004; Olguin et al., 2007). For detection of   
labeled DNA, cells were fixed in methanol for 10 min at 20°C, washed   
in PBS, permeabilized in PBS + 0.2% Triton-X-100 + 1% BSA for 10 min, and 
denatured in 3M HCl for 20 min before incubation with primary antibodies 
overnight at 4°C in PBS + 10% horse serum. Primary antibodies used for immuno-
fluorescence were: chicken polyclonal anti–Syndecan-4 at 1:1,000, rabbit 
polyclonal anti-Hes1 (Millipore) at 1:100, rabbit polyclonal anti-Notch1 cyto-
plasmic domain (Millipore) at 1:200, mouse monoclonal anti-Pax7 (Develop-
mental Studies Hybridoma Bank at Iowa University) at 1:5, rabbit polyclonal 
anti-Pax7 (GeneTex, Inc.) at 1:250, rat polyclonal anti-BrdU (AbD Serotec) at 
1:100, rabbit polyclonal anti-MyoD (Santa Cruz Biotechnology, Inc.) at 1:30, 
rabbit polyclonal anti-myogenin (Santa Cruz Biotechnology, Inc.) at 1:30, rab-
bit polyclonal anti–P-H3 (Millipore) at 1:100, mouse clone B44 recognizing 
IdU (and also BrdU, BD) at 1:400, and rat antibody clone BU1/75 (ICR1) rec-
ognizing CldU (and also BrdU; Novus Biologicals) at 1:200. Secondary anti-
bodies conjugated with Alexa Fluor 594, Alexa Fluor 488, or Alexa Fluor 647 
(Invitrogen) were used at 1:500 dilution. Vectashield with DAPI (Vector Labo-
ratories) was used the mounting medium.
Primers
For Hes1 detection: forward, 5-GACAAACCAAAGACGGCCTCT-3;   
and backward, 5-CCATGATAGGCTTTGATGACTTTCT-3. For Hey2 de-
tection: forward, 5-GGACGAGACCATCGACGTG-3; and backward,   
reduced in sdc3
/ injured muscles compared with wild-type 
controls, the total number of nuclei per tissue area and the total 
muscle weight are indistinguishable in sdc3
/ and wild-type 
injured TA muscles (unpublished data). These data are consis-
tent with the data for cultured sdc3
/ SCs, where we predict 
that sdc3
/ SCs activated by an injury in vivo would maintain 
their proliferation state longer than wild-type cells due to their 
impaired progression through the cell cycle. In further support of 
this idea is the observation that myofiber hypertrophy in sdc3
/ 
regenerating muscles increases gradually over time when com-
paring sdc3
/ TA muscles to wild-type muscles. These sdc3
/ 
phenotypes appear to be largely Notch-dependent because ec-
topic expression of the constitutively active NICD rescues both 
sdc3
/ SC progression through the cell cycle and self-renewal 
in culture. However we cannot completely rule out the possibil-
ity of Syndecan-3 contributions to other signaling pathways.
Genetic ablation of Syndecan-3, a component of the cell 
glycocalix, was expected to affect several signaling pathways 
because the glycocalix is complex and integrates environmental 
signals such that changes or loss of one component affects sev-
eral other components, magnifying downstream effects (Carey, 
1996; Rapraeger, 2000; Tkachenko et al., 2005). Indeed, we 
previously demonstrated that FGF and HGF signaling in sdc3
/ 
cells was enhanced compared with wild-type SCs (Cornelison 
et al., 2004). Ongoing work will further address the mechanisms 
involved in Syndecan-3 interactions with Notch and will clarify 
to what extent other signaling pathways are affected when this 
important component of the SC niche is lost.
Materials and methods
Mice
Mice were housed in a pathogen-free facility, and all procedures and proto-
cols were approved by the Institutional Animal Care and Use Committee at the 
University of Colorado. Control mice were littermate wild-type mice when pos-
sible or age- and sex-matched B6D2F1 (The Jackson Laboratory). Sdc3
/ 
mice were donated by H. Rauvala (University of Helsinki, Helsinki, Finland).
Cell cultures
Primary SCs or myofibers were obtained as described previously from   
3–6-mo-old  female  mice  (Cornelison  et  al.,  2004).  For  clonal  cultures, 
500 cells/cm
2 were plated in growth medium (GM; F12-C + 15% horse 
serum + 20 ng/ml FGF-2). MM14 myoblasts were plated at 100–500 cells/
cm
2 and cultured in GM at 37°C and 5% CO2. When required, 5 µM BrdU 
(Sigma Aldrich) was added for 30 min or for 4 h before fixation. For dou-
ble label experiments, either CldU (United States Biological) or IdU (Sigma-
Aldrich) were added at 6.5 µM 30 min before washing for further chase 
or fixation. Myogenic differentiation was induced by switching the growth 
medium to differentiation medium (F12-C + 2% horse serum).
Affymetrix arrays and analysis
Cells were isolated from mouse hindlimb muscle and sorted for Syndecan-4   
expression  as  described  previously  (Tanaka  et  al.,  2009).  A  mini-
mum  of  at  least  three  independent  age-matched  animals  were  ana-
lyzed  per  time  point.  Total  RNA  was  isolated  using  a  PicoPure  RNA 
Isolation kit (Arcturus) followed by two rounds of linear T7-based am-
plification (RiboAmp HA kit; Arcturus) for an RNA equivalent of 5,000 dual-
positive cells (based on the number of cells collected) per Affymetrix chip.   
Biotin-labeled antisense RNA was generated with an IVT Labeling kit 
(Affymetrix), and labeled cRNA was quantified and analyzed for size 
representation  using  a  BioAnalyzer  (Agilent  Technologies).  5  mg  of 
labeled cRNA was fragmented and hybridized to mouse microarrays 
(430 v. 2; Affymetrix) at the University of Colorado Core facilities; chips 
were scanned on a GeneChip Scanner 3000 (Affymetrix), and intensity   
data were recovered in GeneChip Operating Software (GCOS; Affymetrix).   439 Notch processing requires Syndecan-3 • Pisconti et al.
Notch1 was detected by two distinct primary antibodies produced in two 
different animal species. Anti-Notch1 G20 was produced in a goat then 
detected by anti–goat PLA probe MINUS and anti-Notch1 8G10 produced 
in a Syrian hamster, then detected by biotin-conjugated anti–Syrian ham-
ster followed by anti-biotin PLA probe PLUS.
Microscopy, image processing, and figure preparation
Micrographs were taken with a confocal microscope (TCS SP2 AOBS; 
Leica)  using  dedicated  Leica  software,  or  with  an  epifluorescence   
microscope (Eclipse E800; Nikon) using Slidebook version 4.1 acquisition 
software (Intelligent Imaging Innovations Inc.) coupled to a digital cam-
era (Sensicam; Cooke Optics). Lenses used with the confocal microscope 
were either HC Plan-Apochromat 20×/0.70 IMM CORR CS or HCX Plan-
Apochromat 40×/1.25–0.75 NA. Lenses used with the epifluorescence 
microscope were either 40×/0.75 differential interference contrast M or 
20×/0.50 Ph1 DLL Plan Fluor lenses (Nikon). All digital microscopic im-
ages were acquired at room temperature. The mounting medium for cells 
and sections used for imaging was Vectashield Mounting Medium (Vector 
Laboratories). The fluorochromes used were Alexa Fluor 488, Alexa Fluor 
594, and Alexa Fluor 647 conjugated to secondary antibodies for immuno-
fluorescence, as indicated in the Immunofluorescence section. Texas red 
was incorporated by polymerase reaction into DuoLink
+ complexes, as in-
dicated in the PLA section. For figure preparation, images were exported 
in  Photoshop  (Adobe).  If  necessary,  the  brightness  and  contrast  were 
adjusted for the entire image, the image was cropped, and individual 
color channels were extracted (when required) without color correction or 
gamma adjustments.
Online supplemental material
Fig.  S1  shows  a  schematic  of  the  CldU-IdU  pulse-chase  experiment,   
impaired cell cycle progression, and delayed differentiation onset in 
sdc3
/ SCs compared with wild type SCs. Fig. S2 shows reduced Pax7
+ 
SCs in sdc3
/ muscles compared with wild-type muscles 2 wk and 6 wk 
after injury. Fig. S3 shows reduced Notch signaling in sdc3
/ SCs com-
pared with wild-type SCs despite similar expression levels of Notch recep-
tors. Fig. S4 shows reduced Notch signaling in sdc3
/ injured muscles, 
that cultured sdc3
/ SCs do not respond to Notch stimulation, and that 
reduced Notch signaling and clonal expansion in sdc3
/ SCs are not 
rescued by low-oxygen culture conditions. Fig. S5 shows a schematic of 
Notch signaling transduction and a schematic of the Notch mutants used, 
and also shows that E-6mt ectopic expression produces similar results in 
wild-type and sdc3
/ SCs. Table S1 shows differential gene expression 
values from Affymetrix chips for wild-type and sdc3
/ SCs isolated 12 h 
after muscle injury. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.201003081/DC1.
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